QCM
OLMA icon

Quantinno Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Quantinno Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
95,336
+34,030
+56% +$758K ﹤0.01% 1876
2025
Q4 		$1.53M Buy
61,306
+20,976
+52% +$373K ﹤0.01% 1504
2025
Q3 		$395K Buy
+40,330
New +$242K ﹤0.01% 2228

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Quantinno Capital Management's OLMA Position: Q1 2026 in Review

Quantinno Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 56% in Q1 2026, buying an estimated $758K and bringing the position to 95,336 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

Quantinno Capital Management first reported a position in OLMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.53M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Quantinno Capital Management held 95,336 shares of Olema Pharmaceuticals worth $1.42M as of Q1 2026.
  • Quantinno Capital Management bought 34,030 Olema Pharmaceuticals shares in Q1 2026, an estimated $758K.
  • Olema Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1876 holding.
  • Quantinno Capital Management first reported a position in Olema Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Quantinno Capital Management's Olema Pharmaceuticals position peaked at $1.53M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.